Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Contrast-enhanced Ultrasound in Neoadjuvant Chemotherapy of Breast Cancer

NCT03385200 is registered in ClinicalTrials.gov with RWTH Aachen University as lead sponsor.

NCT NCT03385200
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03385200 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Contrast-enhanced Ultrasound in Neoadjuvant Chemotherapy of Breast Cancer
Lead sponsor
RWTH Aachen University
Phase
Phase 3
Overall status
Unknown status
Start date
December 12, 2016
Completion date
December 12, 2019
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

early primary breast cancer